MARKET WIRE NEWS

Hydromer, Inc. Announces Expansion Into UV Coating and Curing Equipment Manufacturing

MWN-AI** Summary

Hydromer, Inc., a leader in coating technologies for medical devices, announced significant expansion plans on February 10, 2026. The Concord, NC-based company, which specializes in hydrophilic, thromboresistant, and antimicrobial coatings, is venturing into the manufacturing and global supply of innovative UV coating, curing, and testing equipment. This strategic move aims to offer a comprehensive end-to-end solution for medical device manufacturers worldwide.

The expanded equipment platform will combine Hydromer's proprietary coatings with advanced machinery, allowing manufacturers to closely link process parameters with performance outcomes. This integration aims to ensure compliance with international standards, including ISO 13485 and FDA Quality System Regulations (21 CFR Part 820), facilitating safer and more efficient production.

Key components of the new equipment line include automated hydrophilic coating systems that provide uniform applications with minimal manual intervention, a high-throughput modular system designed to enhance production rates while reducing labor demand, and specialized friction testing equipment for precise lubricity evaluations. The automated systems are engineered for ease of use, potentially allowing single-operator functionality.

CEO Michael Torti highlighted the company’s commitment to bridging technological barriers and expediting time-to-market for clients while maintaining rigorous quality standards. With over 40 years of experience, Hydromer aims to leverage its expertise in surface modification and coating solutions to serve a diverse array of industries globally.

As an ISO 9001:2015-certified organization, Hydromer is dedicated to providing reliable and cutting-edge solutions across the United States, Europe, and Asia-Pacific. The news of their expansion taps into the increasingly critical need for innovation in medical device manufacturing, promising enhanced operational efficiency and regulatory compliance.

MWN-AI** Analysis

Hydromer, Inc.'s recent announcement regarding its expansion into the manufacturing of UV coating and curing equipment represents a strategic pivot that could significantly strengthen its market position and offer substantial growth opportunities. The introduction of a comprehensive solution for medical device manufacturers aligns well with industry trends leaning towards automation and efficiency, particularly in the highly regulated medical sector.

The integration of proprietary coatings with high-performance machinery positions Hydromer as a one-stop-shop for manufacturers. This could enhance client relations and streamline their processes, reducing time to market significantly. The equipment offerings, such as the automated high-throughput coating systems, cater to an industry increasingly relying on scalability and operational efficiency. With FDA compliance benchmarks being a priority, Hydromer’s commitment to maintaining quality through strict adherence to ISO and GMP protocols places them in a favorable light among potential clients navigating these stringent regulations.

However, it's crucial to assess potential risks associated with this expansion. The capital investment required for the new manufacturing capabilities and potential shifts in market demand could introduce volatility. It will be essential for Hydromer to execute its rollout effectively while keeping an eye on operational costs.

For investors, this expansion could signal a bullish trend if executed well, particularly given the growing market demand for medical technology and innovative coating solutions. Investors might consider entering positions in Hydromer (OTC: HYDI) if they believe that the company can leverage its competitive advantages to capture a larger share of the market. Careful monitoring of the company’s performance metrics in the coming quarters will be essential, especially as new products hit the market. Overall, this development is a positive indicator of Hydromer’s commitment to innovation and market leadership in the coating industry.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: NewMediaWire

CONCORD, NC - February 10, 2026 (NEWMEDIAWIRE) - Hydromer, Inc. (OTC: HYDI) (the “Company”), a leader in hydrophilic, thromboresistant and antimicrobial coating technologies for over 40 years, was proud to announce its expansion into the manufacturing and global supply of leading-edge UV coating, curing and testing equipment. By integrating proprietary coatings and liners with high-performance machinery, Hydromer now provides a comprehensive, end-to-end solution for medical device manufacturers worldwide.

This integrated platform allows manufactures to correlate process parameters directly with performance outcomes, supporting compliance with SIO 13485 and FDA Quality System Regulations (21 CFR Part 820).

The Company’s expanded equipment platform includes:

  • Hydrophilic Coating Equipment: delivered uniform coating application and UV curing with minimal manual intervention.
  • Automated High-Throughput Coating System: a modular system comprised of load, dip coating and UV curing workstations. The fully automated configuration is designed to be operated by a single operator to increase production rates and reduce reliance on manual labor.
  • Friction Testing Equipment: designed for lubricity tests with precise and repeatable measurements to support performance evaluation and quality control.

“Hydromer has long been focused on coating performance and manufacturing consistency,” said Michael Torti, CEO of Hydromer. “By manufacturing and supplying the equipment used to apply our industry-leading hydrophilic coatings, we eliminate technical barriers and help our clients reduce time to market while maintaining the highest standards of quality and regulatory confidence.”

About Hydromer

Hydromer, Inc. is an ISO 9001:2015 global business-to-business (B2B) surface modification and coating solutions provider offering polymer R&D and manufacturing services capabilities for a wide variety of applications. We are domiciled in Concord, NC. Our customers are located across the United States, Europe and Asia-Pacific. Our facilities are compliant to, Good Manufacturing Practice (GMP), International Organization for Standardization (ISO) 13485, and International Organization for Standardization (ISO) 9001. For over four decades, the Company has developed value-added solutions to serve businesses in domestic and international markets in a wide range of industries. We manage numerous global B2B services such as the sale of proprietary coating formulations, automated coating with UV cure equipment, custom coating services, research and development, analytical testing, technology transfer, and dedicated machinery building, installation, and support. We have successfully developed numerous proprietary formulations and hold patents worldwide.

Contact:
Hydromer Inc.
Info@hydromer.com

Forward-Looking Statements

This press release contains forward-looking statements that are based on Hydromer’s current expectations, estimates, forecasts, and projections. These statements are not guarantees of future performance and involve risks, uncertainties, assumptions, and other factors that are difficult to predict and could cause actual results to differ materially from those expressed or anticipated. We caution readers not to place undue reliance on these forward-looking statements. Hydromer undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

View the original release on www.newmediawire.com

FAQ**

What are the strategic benefits for investors in Hydromer, Inc. (HYDI) following its expansion into UV coating and testing equipment manufacturing in Concord, NC?

Investors in Hydromer, Inc. (HYDI) can benefit strategically from the expansion into UV coating and testing equipment manufacturing in Concord, NC, by tapping into a growing market, enhancing product offerings, increasing revenue streams, and improving competitive positioning.

How does the integration of proprietary coatings with high-performance machinery position Hydromer, Inc. (HYDI) to capitalize on emerging trends in the medical device manufacturing sector?

The integration of proprietary coatings with high-performance machinery positions Hydromer, Inc. (HYDI) to capitalize on emerging trends in the medical device manufacturing sector by enhancing product performance, enabling innovation, and meeting the increasing demand for advanced, customized solutions.

What measures does Hydromer, Inc. (HYDI) implement to ensure compliance with quality standards such as ISO 13485 and FDA regulations, and how does that impact investor confidence?

Hydromer, Inc. implements stringent quality management systems and ongoing audits to adhere to ISO 13485 and FDA regulations, enhancing investor confidence by demonstrating commitment to product safety, reliability, and regulatory compliance in the medical device industry.

Considering the competitive landscape, what unique advantages does Hydromer, Inc. (HYDI) offer to its B2B customers that could drive future revenue growth?

Hydromer, Inc. (HYDI) offers unique advantages such as proprietary polymer technologies, customizable solutions for diverse applications, and a strong focus on sustainability, positioning itself as a valuable partner for B2B customers seeking innovation and eco-friendly options.

**MWN-AI FAQ is based on asking OpenAI questions about Hydromer, Inc. (OTC: HYDI).

Hydromer, Inc.

NASDAQ: HYDI

HYDI Trading

-42.84% G/L:

$0.20 Last:

2,750 Volume:

$0.3499 Open:

mwn-app Ad 300

HYDI Latest News

HYDI Stock Data

$828,348
5,522,318
N/A
N/A
Chemicals
Materials
US

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App